Education
About Us
Working with TipRanks
Follow Us
Marvel Biosciences Corp (TSE:MRVL)
:MRVL
MRVL Stock Chart & Stats
C$0.16
-C$0.01(-6.45%)
At close: 4:00 PM EST
C$0.16
-C$0.01(-6.45%)
Day’s Range― - ―
52-Week RangeC$0.08 - C$0.40
Previous CloseN/A
Volume5.00K
Average Volume (3M)89.38K
Market Cap
C$8.99M
Enterprise ValueC$5.99M
Total Cash (Recent Filing)C$389.02K
Total Debt (Recent Filing)C$1.71M
Price to Earnings (P/E)―
Beta-0.60
Next Earnings
Dec 22, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding58,004,482
10 Day Avg. Volume75,294
30 Day Avg. Volume89,378
Financial Highlights & Ratios
PEG Ratio-0.04
Price to Book (P/B)-1.70
Price to Sales (P/S)0.00
P/FCF Ratio-4.07
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Marvel Biosciences Corp News
MRVL FAQ
What was Marvel Biosciences Corp’s price range in the past 12 months?
Marvel Biosciences Corp lowest stock price was C$0.07 and its highest was C$0.40 in the past 12 months.
What is Marvel Biosciences Corp’s market cap?
Marvel Biosciences Corp’s market cap is C$8.99M.
When is Marvel Biosciences Corp’s upcoming earnings report date?
Marvel Biosciences Corp’s upcoming earnings report date is Dec 22, 2025 which is in 4 days.
How were Marvel Biosciences Corp’s earnings last quarter?
Currently, no data Available
Is Marvel Biosciences Corp overvalued?
According to Wall Street analysts Marvel Biosciences Corp’s price is currently Overvalued.
Does Marvel Biosciences Corp pay dividends?
Marvel Biosciences Corp does not currently pay dividends.
What is Marvel Biosciences Corp’s EPS estimate?
Marvel Biosciences Corp’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Marvel Biosciences Corp have?
Marvel Biosciences Corp has 58,004,482 shares outstanding.
What happened to Marvel Biosciences Corp’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Marvel Biosciences Corp?
Currently, no hedge funds are holding shares in TSE:MRVL
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Marvel Biosciences Corp
Marvel Biosciences Corp (MRVL) is a biotechnology company focused on the research and development of novel therapeutics for the treatment of neurological disorders. The company operates in the pharmaceutical sector, leveraging cutting-edge science to address unmet medical needs. Marvel Biosciences aims to advance its proprietary compounds through clinical development, targeting diseases such as Alzheimer's, depression, and anxiety.
Technical Analysis
Algernon Pharmaceuticals
―
Appili Therapeutics Inc Class A
―
Rakovina Therapeutics Inc
―
MYND Life Sciences
―
―
Options Prices
Currently, No data available
---